8/3/2019 Haemophilia a Done)
1/21
BY
AZHANI ABDUL RAHMAN
FATIN NADZIRAH BINTI MOHAMAD IDRIS
INTAN SUZANA BINTI HASSANIZYAN SYAZNI ABD RAZAK
SITI NAQIUYAH TAN FARRIZAM
SITI SARAH AZMI
8/3/2019 Haemophilia a Done)
2/21
8/3/2019 Haemophilia a Done)
3/21
Haemophilia A is inherited as an X-linked
recessive trait and thus occurs in males and in
homozygous females.
Most common genetic disorder associated with
serious bleeding due to reduction in theamount or activity of factor VII.
Hemophilia A is characterized by deficiency in
factor VIII clotting activity that results inprolonged oozing after injuries, tooth
extractions, or surgery, and delayed or
recurrent bleeding prior to complete wound
healing.
8/3/2019 Haemophilia a Done)
4/21
8/3/2019 Haemophilia a Done)
5/21
SEVERITY FACTOR
VIII
CLOTTINGACTIVITY
SYMPTOMS USUAL AGE
OF
DIAGNOSED
Severe 5% - 35% No spontaneous bleeding;
abnormal bleeding aftermajor
injuries, surgery, or tooth
extractions .
Often later
in life.
8/3/2019 Haemophilia a Done)
6/21
8/3/2019 Haemophilia a Done)
7/21
Haemophilia A is a recessive X-linked genetic
disorder involving a lack of functional clottingFactor VIII .
Factor VIII is an essential blood clotting factor
also known as anti-hemophilic factor (AHF).
In humans, Factor VIII is encoded by the F8
gene.
Defects in this gene results in hemophilia A, a
well known recessive X-linked coagulation
disorder.
8/3/2019 Haemophilia a Done)
8/21
Factor VIII is the precursor to Factor VIIIa, which catalyzesthe activation of Factor IX to IXa.
Protein C and Protein S function to inactivate Factor VIIIa.
FVIII normally circulates in the plasma bound tovonWillebrand Factor. This association has several functionsincluding protecting FVIII from proteolysis, enhancing FVIIIsynthesis, and concentrating FVIII at the site of activehemostasis.
FVIII is a dimer with A,B,and C domains on each monomer.When activated, it becomes a trimer which has lost most ofthe B domain. (This is important concerning FVIIIinhibitors.)
8/3/2019 Haemophilia a Done)
9/21
XX--LINKED RECESSIVE TRAITLINKED RECESSIVE TRAIT
8/3/2019 Haemophilia a Done)
10/21
Females have two copies of the X chromosome, so if the factor VIII gene
on one chromosome doesn't work, the gene on the other chromosome can
do the job of making enough factor VIII.
Males, however, have only one X chromosome, so if the factor VIII gene on
that chromosome is broken, they will have hemophilia A. Thus, mostpeople with hemophilia A are male.
If a woman has a defective factor VIII gene, she is considered a carrier.
This means the defective gene can be passed down to her children.
There are four possible outcomes for the baby of a woman who is a
carrier. These four possibilities are repeated for each and every
pregnancy:
1. A girl who is not a carrier
2. A girl who is a carrier
3. A boy without hemophilia
4. A boy with hemophilia
8/3/2019 Haemophilia a Done)
11/21
8/3/2019 Haemophilia a Done)
12/21
Hemophilia A is the most common severe bleeding disorder
Second most common congenital bleeding disorder ( after vWD)
Bleeding may occur anywhere.
The most common sites of bleeding are into joints (knees, ankles,elbows), into muscles, and from the gastrointestinal tract.
Spontaneous hemarthroses are so characteristic of severe hemophiliathat they are almost diagnostic of the disorder.
Patients with mild hemophilia bleed only in response to major trauma
or surgery.
Patients with moderately severe hemophilia bleed in response to mildtrauma or surgery, and those with severe hemophilia bleedspontaneously.
8/3/2019 Haemophilia a Done)
13/21
The partial thromboplastin time (PTT) is prolonged
Pothrombin time, bleeding time, and fibrinogen
level, are normal.
Levels of factor VIII:C are reduced, butmeasurements of von Willebrand factor are normal
A low platelet count should raise a suspicion of HIV-associated immune thrombocytopenia. As HIV hasbecome relative common in the hemophiliacs due toprevious infected blood transfusions.
8/3/2019 Haemophilia a Done)
14/21
The finding of a reduced factor VIII:C level will distinguishthis disorder from other causes of prolonged PTT
Clinically, factor VIII hemophilia is indistinguishable fromfactor IX hemophilia ( Hemophilia B)
In cases of mild hemophilia, the disorder needs to bedistinguished from von Willebrand's disease by VIII:A assay,
which shows normal levels of factor VIII antigen in theformer.
Female carriers can usually be identified by the presence oflow or normal levels of factor VIII:C with normal levels offactor VIII antigen
8/3/2019 Haemophilia a Done)
15/21
8/3/2019 Haemophilia a Done)
16/21
Bleeding into joints, with associated pain andswelling.
Blood in the urine or stool
Bruising
Gastrointestinal tract and urinary tract hemorrhage.
Prolonged bleeding from cuts, tooth extraction, andsurgery
Spontaneous bleeding.
8/3/2019 Haemophilia a Done)
17/21
8/3/2019 Haemophilia a Done)
18/21
Standard treatment : replacing the missing clotting factor
Mild hemophilia : desmopressin (DDAVP), which helps the bodyrelease factor VIII that is stored within the lining of blood vessels.
People with hemophilia and their families can be taught to give
factor VIII concentrates at home at the first signs of bleeding.
People with severe forms of the disease may need regular
preventative treatment.
Depending on the severity of the disease, DDAVP or factor VIII
concentrate may be given before having dental extractions and
surgery to prevent bleeding.
Immunization with hepatitis B vaccine.
Patients who develop an inhibitor to factor VIII may require
treatment with other clotting factors such as factor VIIa.
8/3/2019 Haemophilia a Done)
19/21
8/3/2019 Haemophilia a Done)
20/21
Roberts HR. Hemophilia A and hemophilia B. In: Lichtman MA, et al., eds.
Williams Hematology. 7th ed. New York, NY: The McGraw-Hill Companies,
Inc.; 2006:chap 115.
Zhang B, Ginsburg D. Familial multiple coagulation factor deficiencies. In:
Colman RW et al (eds) Hemostasis and Thrombosis: Basic Principles and
Clinical Practice, 5 ed. Lippincott-Raven, Philadelphia, pp 953-9. 2006
Bagnall RD, Giannelli F, Green PM. Int22h-related inversions causing
hemophilia A: a novel insight into their origin and a new morediscriminant PCR test for their detection. J Thromb Haemost. 2006; 4: 591
8. [PubMed]
http://en.wikipedia.org/wiki/Haemophilia_A
[1] Kumar P, Clark M. Clinical Medicine. Fourth Ed. WB Saunders, 1998. pp
404 -406
Cheryl Brower, RN, MSPH.Clinical Nurse Specialist ,Puget Sound Blood
Center ,Seattle
8/3/2019 Haemophilia a Done)
21/21